Infinity Pharmaceuticals reported $89K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Amgen AMGN:US $ 31247M 849M
AstraZeneca AZN:LN 387M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cytori Therapeutics CYTX:US $ 0.02M 0.01M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Genocea Biosciences GNCA:US $ 0.06M 0M
Gilead Sciences GILD:US $ 1M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Infinity Pharmaceuticals INFI:US $ 0.09M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Novartis NOVN:VX SF 901M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Tg Therapeutics TGTX:US $ 0.14M 0M
Vascular Biogenics VBLT:US 173K 1.6M
YTE INCY:US $ 0.22M 0M